Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001179110-17-000420

Director acquired 8,660 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Malley Thomas Director 2016-12-30 Grant or award +8,660 $1.53 $13,250 190,023 D
Loading xslF345X03/edgar.xml…